PARSIPPANY, N.J. and INDIANAPOLIS, Oral antiplatelet therapy Effient® (prasugrel) has been added to the updated clinical practice guidelines as a Class I recommended treatment option for patients ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results